Accent Biosciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 58.50 Cr
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 332.85%
About Accent Biosciences
Accent Biosciences Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 February 2021 (Three years and 11 months 25 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹58.50 Cr.
Ghanshyam Patel, Vasant Patel, Bhupeshkumar Rasiklal, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24299GJ2021PTC119892
- Company No.
119892
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Accent Biosciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupeshkumar Rasiklal  | Director | 02-Feb-2021 | Current |
| Ghanshyam Patel | Director | 02-Feb-2021 | Current |
| Vasant Patel | Director | 02-Feb-2021 | Current |
| Nilesh Patel | Director | 02-Feb-2021 | Current |
Financial Performance of Accent Biosciences.
Accent Biosciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Accent Biosciences?
In 2023, Accent Biosciences had a public holding of 62.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Claroid Pharmaceuticals LimitedGhanshyam Patel is a mutual person
Accent Microcell LimitedGhanshyam Patel and Vasant Patel are mutual person
Agistin Biotech Private LimitedVasant Patel is a mutual person
Adalyn Exim LlpBhupeshkumar Rasiklal is a mutual person
- Angiras Surgical Llp
Bhupeshkumar Rasiklal is a mutual person
- Debis Surgical Llp
Bhupeshkumar Rasiklal is a mutual person
Charges (Loans)
₹585.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 58.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jan 2023 | Hdfc Bank Limited | ₹26.75 Cr | Open |
| 05 Jan 2023 | Hdfc Bank Limited | ₹31.75 Cr | Open |
How Many Employees Work at Accent Biosciences?
Accent Biosciences has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accent Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accent Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.